260 publications
Sort by: Date / Relevance
Olaparib (Lynparza®) for the maintenance treatment of adult patients with carcinoma of the ovaries, tubes or peritoneum
Zorginstituut Nederland has completed its assessment whether olaparib (Lynparza®) as a monotherapy for the maintenance treatment ...
Trientine tetrahydrochloride (Cuprior®) the treatment of Wilson’s disease
Zorginstituut Nederland has completed its assessment whether trientine tetrahydrochloride (Cuprior®) is interchangeable with a ...
Hydroquinine (Inhibin®) for patients with nocturnal muscle cramps
Zorginstituut Nederland has assessed whether hydroquinine (Inhibin®) should be included in the medication reimbursement system ...
Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations
Zorginstituut Nederland has completed its assessment whether voretigene neparvovec (Luxturna®) for the treatment of vision loss ...
Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors
Zorginstituut Nederland has completed its assessment whether emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in ...
Metreleptin (Myalepta®) for treatment of lipodystrophy
Zorginstituut Nederland has completed its assessment whether metreleptin (Myalepta®) for treatment of lipodystrophy can be ...
Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome
Zorginstituut Nederland has completed its assessment whether ciclosporin (Ikervis®) for the treatment of severe keratitis in ...
Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma
Zorginstituut Nederland has completed its assessment of dabrafenib (Tafinlar®) in combination with trametinib (Mekinist®) for the ...
Explanation of the Interest Form - MEB-ZIN Parallel Procedures pilot
Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient ...
Erenumab (Aimovig®) for the prophylaxis of adults with migraine
Zorginstituut Nederland has completed its assessment whether erenumab (Aimovig®) for the prophylaxis of adults with migraine, can ...